Format
Sort by

Send to

Choose Destination

Search results

Items: 4

1.

Outcome of Pancreatic Cancer Surveillance Among High-Risk Individuals Tested for Germline Mutations in BRCA1 and BRCA2.

Saldia A, Olson SH, Nunes P, Liang X, Samson ML, Salo-Mullen E, Marcell V, Stadler ZK, Allen PJ, Offit K, Kurtz RC.

Cancer Prev Res (Phila). 2019 Jul 23. doi: 10.1158/1940-6207.CAPR-18-0272. [Epub ahead of print]

PMID:
31337648
2.

Germline SDHA mutations in children and adults with cancer.

Dubard Gault M, Mandelker D, DeLair D, Stewart CR, Kemel Y, Sheehan MR, Siegel B, Kennedy J, Marcell V, Arnold A, Al-Ahmadie H, Modak S, Robson M, Shukla N, Roberts S, Vijai J, Topka S, Kentsis A, Cadoo K, Carlo M, Latham Schwark A, Reznik E, Dinatale R, Hechtman J, Borras Flores E, Jairam S, Yang C, Li Y, Bayraktar EC, Ceyhan-Birsoy O, Zhang L, Kohlman W, Schiffman J, Stadler Z, Birsoy K, Kung A, Offit K, Walsh MF.

Cold Spring Harb Mol Case Stud. 2018 Aug 1;4(4). pii: a002584. doi: 10.1101/mcs.a002584. Print 2018 Aug.

3.

The use of early sea urchin embryos in anticancer drug testing.

Nishioka D, Marcell V, Cunningham M, Khan M, Von Hoff DD, Izbicka E.

Methods Mol Med. 2003;85:265-76. Review. No abstract available.

PMID:
12710214
4.

Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos.

Izbicka E, Nishioka D, Marcell V, Raymond E, Davidson KK, Lawrence RA, Wheelhouse RT, Hurley LH, Wu RS, Von Hoff DD.

Anticancer Drug Des. 1999 Aug;14(4):355-65.

PMID:
10625928

Supplemental Content

Loading ...
Support Center